The Court construes 26 disputed terms for four patents-in-suit
Boston Scientific Corporation, et al. v. Johnson & Johnson, Inc., et al., Civ. No.07-333-SLR; Civ. No. 07-348-SLR; Civ. No. 07-409-SLR; Civ. No. 07-765-SLR, January 20, 2010.
Robinson, J. The Court provides construction for 26 claims following Markman Hearing.
The Court construes 26 disputed terms for the four patents-in-suit. The patents-in-suit relate to drug-eluting coronary stents which are used in the treatment of coronary artery disease.

